相似文献
1
Laboratory Diagnosis of Sepsis? No SIRS, Not Just Yet.
J Clin Microbiol. 2015 Aug;53(8):2404-9. doi: 10.1128/JCM.03681-14. Epub 2015 Jan 28.
2
Clinical evaluation of multiple inflammation biomarkers for diagnosis and prognosis for patients with systemic inflammatory response syndrome.
J Clin Microbiol. 2014 Nov;52(11):4063-6. doi: 10.1128/JCM.01954-14. Epub 2014 Sep 3.
3
Sepsis biomarkers in neutropaenic systemic inflammatory response syndrome patients on standard care wards.
Eur J Clin Invest. 2015 Aug;45(8):815-23. doi: 10.1111/eci.12476.
4
5
6
Use of a Combination Biomarker Algorithm To Identify Medical Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection.
Antimicrob Agents Chemother. 2015 Oct;59(10):6494-500. doi: 10.1128/AAC.00958-15. Epub 2015 Aug 3.
7
Evaluation of the systemic inflammatory response syndrome criteria for the diagnosis of sepsis due to maternal bacteremia.
Int J Gynaecol Obstet. 2016 Apr;133(1):116-9. doi: 10.1016/j.ijgo.2015.09.017. Epub 2016 Jan 6.
8
Evaluation of usefulness of myeloperoxidase index (MPXI) for differential diagnosis of systemic inflammatory response syndrome (SIRS) in the emergency department.
Emerg Med J. 2015 Apr;32(4):304-7. doi: 10.1136/emermed-2013-203137. Epub 2014 Jan 28.
9
Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis-experience from two prospective cohorts.
Immunobiology. 2013 Oct;218(10):1227-34. doi: 10.1016/j.imbio.2013.04.010. Epub 2013 Apr 24.
10
Laboratory microbiology to clinical microbiology: are we ready for a transition?
Indian J Med Microbiol. 2009 Apr-Jun;27(2):97-9. doi: 10.4103/0255-0857.49422.
引用本文的文献
1
When Cultures Fail: Postmortem Decoy Receptor 3 (DcR3) as a Marker of Antemortem Sepsis.
Acad Forensic Pathol. 2019 Mar;9(1-2):15-23. doi: 10.1177/1925362119851075. Epub 2019 Sep 6.
2
Physician agreement on the diagnosis of sepsis in the intensive care unit: estimation of concordance and analysis of underlying factors in a multicenter cohort.
J Intensive Care. 2019 Feb 21;7:13. doi: 10.1186/s40560-019-0368-2. eCollection 2019.
3
Infection markers as predictors of Bacteremia in an Intensive Care Unit: A prospective study.
Pak J Med Sci. 2018 Nov-Dec;34(6):1517-1524. doi: 10.12669/pjms.346.15665.
4
Implementation of the Procalcitonin Assay in a Rural Hospital.
Hosp Pharm. 2018 Dec;53(6):395-402. doi: 10.1177/0018578718762128. Epub 2018 Mar 7.
5
Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational study.
PLoS One. 2018 Oct 17;13(10):e0205924. doi: 10.1371/journal.pone.0205924. eCollection 2018.
6
Relationship of Serum Procalcitonin, C-reactive Protein, and Lactic Acid to Organ Failure and Outcome in Critically Ill Pediatric Population.
Indian J Crit Care Med. 2018 Feb;22(2):91-95. doi: 10.4103/ijccm.IJCCM_4_17.
7
To What Extent Are the Terminal Stages of Sepsis, Septic Shock, Systemic Inflammatory Response Syndrome, and Multiple Organ Dysfunction Syndrome Actually Driven by a Prion/Amyloid Form of Fibrin?
Semin Thromb Hemost. 2018 Apr;44(3):224-238. doi: 10.1055/s-0037-1604108. Epub 2017 Aug 4.
本文引用的文献
1
An Endotoxin Tolerance Signature Predicts Sepsis and Organ Dysfunction at Initial Clinical Presentation.
EBioMedicine. 2014 Nov 1;1(1):64-71. doi: 10.1016/j.ebiom.2014.10.003.
2
Prognostic evaluation of severe sepsis and septic shock: procalcitonin clearance vs Δ Sequential Organ Failure Assessment.
J Crit Care. 2015 Feb;30(1):219.e9-12. doi: 10.1016/j.jcrc.2014.08.018. Epub 2014 Sep 10.
3
Elevated biomarkers of endothelial dysfunction/activation at ICU admission are associated with sepsis development.
Cytokine. 2014 Oct;69(2):240-7. doi: 10.1016/j.cyto.2014.06.010. Epub 2014 Jul 12.
4
Biomarkers for sepsis.
Biomed Res Int. 2014;2014:547818. doi: 10.1155/2014/547818. Epub 2014 Mar 30.
5
Serum levels of procalcitonin as a biomarker for differentiating between sepsis and systemic inflammatory response syndrome in the neurological intensive care unit.
J Clin Neurosci. 2014 Jul;21(7):1153-8. doi: 10.1016/j.jocn.2013.09.021. Epub 2013 Dec 2.
6
Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit.
PLoS One. 2014 Jan 27;9(1):e87315. doi: 10.1371/journal.pone.0087315. eCollection 2014.
7
Utility of sepsis biomarkers and the infection probability score to discriminate sepsis and systemic inflammatory response syndrome in standard care patients.
PLoS One. 2013 Dec 11;8(12):e82946. doi: 10.1371/journal.pone.0082946. eCollection 2013.
8
Biomarkers predicting sepsis in polytrauma patients: Current evidence.
Injury. 2013 Dec;44(12):1680-92. doi: 10.1016/j.injury.2013.09.024. Epub 2013 Sep 20.
9
In search of biomarkers for diagnosing and managing neonatal sepsis: the role of angiopoietins.
J Matern Fetal Neonatal Med. 2013 Oct;26 Suppl 2:24-6. doi: 10.3109/14767058.2013.830411.
10
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.
Lancet Infect Dis. 2013 Mar;13(3):260-8. doi: 10.1016/S1473-3099(13)70001-X.
Zotero 插件